The study was undertaken to investigate the interaction between the release of endothelin-1 (ET-1) and prolactin (PRL) from human decidualized endometrial cells, and the effects of transforming growth factor (TGF)-b1 on the release of ET-1 and PRL from human decidual cells in the early stage of pregnancy. Stromal cells derived from human endometrial tissues were cultured on a type-1 collagen membrane in serum-free medium with or without 100 nmol/l oestradiol and 1 mmol/l medroxyprogesterone acetate (MPA) for 12 days. In addition, decidual cells of early pregnancy were cultured with or without TGF-b1 for 48 h. PRL and ET-1 levels in the media were measured by a specific enzyme immunoassay and RIA respectively.
Introduction
During pregnancy, human decidual tissues synthesize and release prolactin (PRL) (1) with an amino acid sequence identical to that of pituitary PRL (2). These observations suggest that the decidua possesses paracrine activity and is the source of PRL in amniotic fluid. In addition, progesterone stimulates dose-and timedependent production and secretion of PRL in the human endometrium in a paracrine manner (3, 4). However, the regulation of the synthesis and release of PRL from decidualized endometrium, which is in large part different from the regulation of pituitary PRL (5), has not been precisely defined.
Endothelins (ETs) are potent vasoactive agents with 21 amino acid residues isolated from porcine aortic endothelial cells (6). Genomic sequencing has identified three distinct isopeptides: ET-1, ET-2 and ET-3 (7). Recent studies have shown that ETs are also produced by other tissues, including female reproductive tissues, and that they have biological actions on the human reproductive systems (8, 9). We previously found that human decidual cells of early pregnancy and human endometrial cells synthesized and released ET-1 and that they possessed specific functional receptors for ETs coupled to phosphoinositide hydrolysis (8, 10). ET may have a physiological role in the autocrine/paracrine regulation of hormone release (11), uterine blood flow (12) and cell proliferation (10) in human endometrial and decidual cells. Although Chao et al. (11) reported that ET-1 inhibited the basal release of PRL from human decidual cells at term in a time-and dose-dependent manner, data on the relationship between these two hormones, especially in the implantation periods, are limited. In this study, we investigated the relationship between the regulation of the release of ET-1 and PRL in human decidualized endometrium and human decidua of early pregnancy.
The role of transforming growth factor (TGF)-b in human decidualized endometrium is a subject of intense interest at present, and it has been shown that TGF-b has an important role in implantation and decidual function (12). Interestingly, the mRNAs for TGF-b have been detected in human decidua (13), and TGF-b is reported to inhibit the release of decidual PRL (14) . The present study was also undertaken to investigate the effect of TGF-b on the release of ET-1 and PRL from human decidual cells in vitro. 
Materials and methods

Compounds
Cell culture of human endometrial stromal cells
Human endometrial tissues in the proliferative phase of the normal menstrual cycle were quickly scraped from the uterus of women undergoing hysterectomy for benign disease. The cycle date of each specimen was confirmed by the menstrual history and histological examination. Informed consent for the use of these samples was obtained from each woman before surgery. The consent forms and protocols were approved by the Institutional Review Board of Tokyo Medical and Dental University. Endometrial tissue was washed thoroughly with physiological saline, minced with scissors and enzymatically dispersed with collagenase (2 g/l) and deoxyribonuclease (DNase, 50 mg/l). Endometrial stromal cells were separated from epithelial cells by filtration through 38 mm steel mesh, as described previously (15) . The cells were suspended in R.P.M.I-1640 containing 10% FCS in plastic T flasks (75 cm 2 , Falcon, NJ, USA) in a humidified 37 ЊC atmosphere of 5% CO 2 -95% air. After 1 week of culture, stromal cells were subcultured by the standard methods of trypsinization, and seeded on a type-1 collagen membrane at a concentration of 10 6 cells/well. The purity of the stromal cells was almost 100%, confirmed immunohistochemically using vimentin, a known stromal cell marker (10). After cells had grown to confluence, they were cultured in serum-free medium with or without 100 nmol/l oestradiol and 1 mmol/l medroxyprogesterone acetate (MPA) for 12 days (we could not obtain adequate data from cell cultures in oestradiol alone or MPA alone). The medium was changed every 4 days, centrifuged and stored until assayed. At the end of the culture period, cells were counted by the citric acidcrystal violet method (16) .
Cell culture of decidua from early pregnancy
Decidual tissue from normal early pregnancies (6-8 weeks of gestation) was quickly removed by dilatation and curettage from women undergoing early termination of pregnancy. Informed consent for this study was obtained from each patient after full explanation of the purpose and nature of all procedures used. After specimens were thoroughly washed with physiological saline they were cut into multiple blocks from which capillaries and blood clots were eliminated, enzymatically dispersed with collagenase and DNase, and then filtered to obtain an enriched fraction of decidual cells as described previously (8). Decidual cells were seeded in a collagen-coated 24 well plate at a density of approximately 10 6 viable cells/well in R.P.M.I-1640 medium containing 10% FCS and antibiotics. Cells were allowed to attach for 24 h in a humidified 37 ЊC atmosphere of 5% CO 2 -95% air. On the day of the experiment, the cells were cultured with various concentrations of TGF-b1 for 48 h. At the end of the culture period, the medium was removed from the cells and stored frozen until 
Assays of ET-1 and PRL
Endothelin-1 in the conditioned medium was measured by RIA according to a previously described method (8) using [ 125 I]ET-1 as the tracer and synthetic ET-1 as the standard. The antibody used in the RIA demonstrated 100% cross-reactivity with ET-1, ET-2 and ET-3, but less than 1% with big ET-1. The final dilution of the antibody was 1:12 000, and the sensitivity was 1 fmol/ tube. The coefficients of intra-and interassay variation were 3.2% and 8.6% respectively.
Prolactin in the medium was measured by a commercial enzyme immunoassay kit (Mochida Pharmaceutical Co. Tokyo, Japan). The coefficients of intraand interassay variation did not exceed 10% (17) .
Statistical methods
Data are expressed as the mean Ϯ S.D. of groups comprising four wells. Statistical significance was determined by analysis of variance (ANOVA) and linear regression analysis. A level of P < 0.05 was accepted as statistically significant. All experiments were repeated two or more times to ensure the reproducibility of results. The results of one representative experiment are reported in each figure.
Results
Release of ET-1 and PRL from in vitro decidualized endometrial cells
In in vitro decidualized endometrial cells induced by ovarian steroid hormones, PRL release increased timedependently over the 12-day culture period (Fig. 1) and PRL release was significantly greater in hormone-treated cells compared with the control preparation (without oestradiol and MPA) (P < 0.02; Fig. 2 ). ET-1 release decreased time-dependently over the 12-day culture period in decidualized cells and this release was greatest
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Figure 2 Effects of ovarian steroid hormones on total release of PRL (A) and ET-1 (B) from human endometrial stromal cells. The cells were incubated at 37 ЊC in the presence (E 2 þ P) and absence (Cont.) of 100 nmol/l oestradiol and 1 mmol/l MPA for 12 days. Data show the total amount of PRL and ET-1 in 12-day culture. Each bar represents the mean of four wells (þ S.D.). *P < 0.02 compared with control. during the first 4 days of culture (44.5Ϯ3.9 mg/l per 10 6 cells) (Fig. 1) . Total ET-1 release was significantly smaller from in vitro decidualized endometrial cells compared with control cells for 12-day culture (P < 0.02; Fig. 2 ).
There was a significant negative correlation between PRL and ET-1 release (r ¼ ¹0.732, P < 0.001; Table 1 ).
Release of ET-1 and PRL from the decidua of early pregnancy
TGF-b1 (1 and 10 mg/l) significantly attenuated PRL release after 48 h of culture, to 89.4% and 86.8% of the respective control values (P < 0.002-0.001; Fig. 3 ). TGF-b1 (0.01-10 mg/l) increased ET-1 release from cultured decidual cells of early pregnancy in a dosedependent manner by 15-62% after 48 h of culture (P < 0.02-0.001; Fig. 4 ). There was a significant negative correlation between PRL and ET-1 release (r ¼ ¹0.709, P < 0.001; Table 1 ). In addition, TGF-b1 had no significant effect on the proliferation of decidual cells after 48 h of culture, as measured by incorporation of [H 3 ]thymidine into these cells (data not shown).
Discussion
Human endometrial epithelial and stromal cells synthesize and release ET-1 throughout the normal menstrual cycle. They possess specific functional receptors for ETs, which are coupled to phosphoinositide breakdown and to the increase of cAMP induced by ET-1 stimulation (10, 12). Messenger RNAs for prepro-ET-1, ET A and ET B receptor have also been identified in the human endometrium (10, 18). These findings suggest that ET-1 may have a potential autocrine or paracrine function, or both, in human endometrial cells. The present study showed that oestradiol and MPA significantly attenuated ET-1 release but increased PRL release from cultured endometrial stromal cells, indicating that the regulation of ET-1 release differs from that of PRL release in these cells. The decrease in the ET-1 concentration induced by ovarian steroids may have been due to the effect of membrane metalloendopeptidase, which catalyses the degradation of ET, because progesterone increases the activity of membrane metalloendopeptidase in human endometrium (19, 20) . Human decidua synthesize and release PRL principally under the influence of progesterone (21) . The release of decidual PRL is modulated by several other factors, including growth factors (22) , prostaglandin precursors (23) , and local substances secreted by the placenta or the decidua (24) . However, Northern blot analysis has demonstrated expression of mRNA for prepro-ET-1 in human decidua, which releases ET-1 and contains specific receptors for ETs (8). Chao et al. (11) have demonstrated that ET inhibits the basal release of PRL from human decidual cells in a time-and dosedependent manner. The effect of ET on the release of PRL from decidual cells is similar to its effect in the pituitary, where ET also inhibits basal PRL release (25) . Macrophages and decidual cells synthesize ET and decidual tissue contains specific receptors for ETs, suggesting that the inhibitory action of ET on basal and stimulated PRL release may result from an autocrine or paracrine effect, or both (11).
TGF-b exhibits stimulatory and inhibitory effects on the proliferation, differentiation and other functions of a variety of cells (26) . The TGF-b family consists of at least five distinct gene products, TGF-bs 1-5, that show a high degree of homology (70-80%) in their amino acid sequences (27) . TGF-b mRNA has been detected in human decidua (13) and TGF-b-like activity has been observed in human amniotic fluid at term (28) . In cultured human amnion cells, TGF-b stimulates expression of ET-1 mRNA and release of ET-1 (28) . In addition, the production and release of ET-1 by endometrial cells were stimulated by TGF-b in an autocrine/paracrine mechanism (29) . In the present study, TGF-b1 also stimulated the release of ET-1 from human decidual cells. In contrast, TGF-b1 attenuated the release of PRL in human decidual cells of early pregnancy, which is consistent with the results of a previous study in these cells from term pregnancies (14) . Our data revealed that there was a significant negative correlation between PRL and ET-1 release from human decidual cells, suggesting that the regulation of ET-1 release differs from that of PRL release in the decidua of early pregnancy, as in the endometral stromal cells. Furthermore, Moulton (30) has suggested that TGF-b secreted by human endometrial stromal cells may control the apoptosis associated with development of the trophoblast. These data indicate that TGF-b has important effects on intrauterine conditions during early pregnancy.
In conclusion, we observed a significant negative correlation between PRL and ET-1 release from human decidualized endometrial cells, showing that the regulation of PRL release differs from that of ET-1 release. Furthermore, TGF-b1 stimulated the release of ET-1 and attenuated the release of PRL from human decidual cells in early pregnancy by an autocrine/ paracrine mechanism.
